Research Story featuring Carlos Arteaga, MD
978 views · Published 6 September 2016 · 0:31 · Indexed 12 November 2026
Channel: American Cancer Society · 2016 · Nonprofits & Activism
Carlos Arteaga, MD, is a very accomplished American Cancer Society Clinical Research Professor at Vanderbilt University who studies many aspects of breast cancer. Currently, he’s looking at ways to overcome resistance to Herceptin. Oneof his very first large research grants was from the American Cancer Society. Arteaga credits us with being critical to his success. He is part of the community of investigators who contributed to the development of four anti-HER2 drugs. Thanks in part to Arteaga’s work, the majority of women with HER2-positive breast cancer can be cured of their disease.
More from this channel
-
9:16
Access to Care Press Conference : Part 1
-
10:00
Access to Care Press Conference : Part 2
-
10:28
Access to Care Press Conference : Part 3
-
9:54
Access to Care Press Conference : Part 4
-
9:57
Access to Care Press Conference : Part 5
-
6:49
Access to Care Press Conference : Part 6
-
4:40
Access to Care 201
-
1:01
Learn.Speak.Act. : MIKE-E Video (Long Version)